Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas Disclosure of Research Ananlyst Annual Compliance Audit Report
Downloads News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
Ajanta Pharma Ltd
Pharmaceuticals - Indian - Formulations
BSE Code 532331 border-img ISIN Demat INE031B01049 border-img Book Value 338.05 border-img NSE Symbol AJANTPHARM border-img Div & Yield % 0.88 border-img Market Cap (₹ Cr.) 39840.1 border-img P/E 42.31 border-img EPS 75.36 border-img Face Value 2
Mar 2026
(₹ Cr.) 		Mar 2025
(₹ Cr.) 		Mar 2024
(₹ Cr.) 		Mar 2023
(₹ Cr.) 		Mar 2022
(₹ Cr.) 		Mar 2021
(₹ Cr.)
SOURCES OF FUNDS :       
Share Capital 25.0725.0725.2725.2717.1717.39
Reserves Total 4198.463600.243388.303221.183152.012867.59
Equity Share Warrants 0.000.000.000.000.000.00
Equity Application Money 0.000.000.000.000.000.00
Total Shareholders Funds 4223.533625.313413.573246.453169.182884.98
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 34.6931.1730.5232.9020.4925.91
Total Debt 34.6931.1730.5232.9020.4925.91
Other Liabilities 54.6483.3243.2527.8323.4122.52
Total Liabilities 4312.863739.803487.343307.183213.082933.41
APPLICATION OF FUNDS :       
Gross Block 2996.352759.582355.332246.282163.182086.54
Less : Accumulated Depreciation 1151.581017.62890.44762.27670.86567.75
Less:Impairment of Assets 0.000.000.000.000.000.00
Net Block 1844.771741.961464.891484.011492.321518.79
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress 258.05176.27256.45209.47152.86108.19
Producing Properties 0.000.000.000.000.000.00
Investments 606.24481.84367.14553.26164.85156.88
Current Assets, Loans & Advances       
Inventories 844.71739.29677.79683.77635.11634.22
Sundry Debtors 1365.771225.811207.67977.631043.62782.30
Cash and Bank Balance 90.5549.7263.06269.92145.25151.98
Loans and Advances 257.78122.53163.10109.60111.17128.72
Total Current Assets 2558.812137.352111.622040.921935.151697.22
Less : Current Liabilities and Provisions       
Current Liabilities 850.04663.96566.54874.39446.80459.91
Provisions 35.8839.9855.0625.5018.7446.57
Total Current Liabilities & Provisions 885.92703.94621.60899.89465.54506.48
Net Current Assets 1672.891433.411490.021141.031469.611190.74
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets 39.9937.2535.0034.3028.150.00
Deferred Tax Liability 157.93147.76143.50132.02130.0292.17
Net Deferred Tax -117.94-110.51-108.50-97.72-101.87-92.17
Other Assets 48.8516.8317.3417.1335.3150.98
Total Assets 4312.863739.803487.343307.183213.082933.41
Contingent Liabilities 8.128.124.944.557.2882.90
`

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.   Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day...... issued in the interest of investors.    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.      No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account   |    Website Accessibility Statement

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio Manager You can call us at +91-471-4093333, Or you can mail us at helpdesk@capstocks.com

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 | DP: IN-DP-CDSL-203-2003 | PMS: INP000001066 | Research Entity SEBI Reg No: INH200003109 | AMFI registered Mutual Fund & Specialised Investment Fund Distributor (AMFI Registration Number - 20149) |
BSE Enlisted No: 5189 | Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
imsl-img
close
refresh